PubRank

Richard J Rodeheffer

Author PubWeight™ 140.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003 13.79
2 Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004 8.97
3 Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol 2008 4.24
4 Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009 4.16
5 Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005 3.89
6 Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007 3.78
7 Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002 3.68
8 Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005 3.34
9 Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 2011 2.86
10 Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc 2005 2.71
11 Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 2009 2.70
12 Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 2005 2.69
13 Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 2003 2.62
14 Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol 2009 2.53
15 Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation 2007 2.43
16 Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc 2006 2.37
17 Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol 2009 2.34
18 Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 2012 2.26
19 Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA 2009 2.10
20 Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 2006 2.09
21 Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol 2003 2.03
22 Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2006 1.98
23 Heart failure after myocardial infarction: a review. Am J Med 2002 1.76
24 Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 2007 1.72
25 Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 2007 1.69
26 Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 2004 1.67
27 Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol 2012 1.61
28 Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction. Eur Heart J 2012 1.58
29 Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension 2006 1.52
30 Participation bias in a population-based echocardiography study. Ann Epidemiol 2004 1.48
31 The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. J Am Coll Cardiol 2010 1.43
32 Unrecognized myocardial infarction: the association with cardiopulmonary symptoms and mortality is mediated via echocardiographic abnormalities of global dysfunction instead of regional dysfunction: the Olmsted County Heart Function Study. Am Heart J 2006 1.38
33 Association of newer diastolic function parameters with age in healthy subjects: a population-based study. J Am Soc Echocardiogr 2003 1.32
34 Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol 2012 1.29
35 Central obesity: association with left ventricular dysfunction and mortality in the community. Am Heart J 2008 1.24
36 Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol 2007 1.23
37 Defining unrecognized myocardial infarction: a call for standardized electrocardiographic diagnostic criteria. Am Heart J 2004 1.22
38 A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community. J Am Coll Cardiol 2011 1.20
39 Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J Clin Oncol 2004 1.16
40 Longitudinal changes in left ventricular stiffness: a community-based study. Circ Heart Fail 2013 1.09
41 The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction. J Card Fail 2008 1.08
42 Abnormal cardiac structure and function in the metabolic syndrome: a population-based study. Mayo Clin Proc 2008 1.07
43 Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol 2010 1.04
44 Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy. J Heart Lung Transplant 2008 1.03
45 Clinical predictors of exercise capacity 1 year after cardiac transplantation. J Heart Lung Transplant 2003 1.02
46 Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study. Hypertension 2013 1.02
47 A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. Clin Endocrinol (Oxf) 2012 1.02
48 Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis 2010 1.01
49 The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays. Mayo Clin Proc 2011 0.99
50 Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study. Am Heart J 2003 0.98
51 Outcome of patients with low ejection fraction undergoing coronary artery bypass grafting: renal function and mortality after 3.8 years. Circulation 2006 0.98
52 Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study. Mayo Clin Proc 2011 0.97
53 Do rheumatoid arthritis patients have a higher risk for sleep apnea? J Rheumatol 2009 0.96
54 Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft. Transplantation 2008 0.95
55 Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem 2013 0.95
56 Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J Heart Lung Transplant 2009 0.95
57 Prevalence of syncope in a population aged more than 45 years. Am J Med 2006 0.93
58 Increased serum N-terminal pro-B-type natriuretic peptide levels in patients with medial arterial calcification and poorly compressible leg arteries. Arterioscler Thromb Vasc Biol 2010 0.92
59 Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. Am J Cardiol 2012 0.91
60 Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant 2005 0.91
61 National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathy. Mayo Clin Proc 2006 0.91
62 K(ATP) channel polymorphism is associated with left ventricular size in hypertensive individuals: a large-scale community-based study. Hum Genet 2008 0.91
63 Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation 2011 0.91
64 Risk factor implications of incidentally discovered uncomplicated bundle branch block. Mayo Clin Proc 2005 0.90
65 Safety, acceptance, and physiologic effects of sauna bathing in people with chronic heart failure: a pilot report. Arch Phys Med Rehabil 2009 0.90
66 Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant 2007 0.85
67 Combined heart and liver transplantation: a single-center experience. Transplantation 2009 0.84
68 Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum 2013 0.83
69 Echocardiographic characteristics of electrocardiographically unrecognized myocardial infarctions in a community population. Am J Cardiol 2005 0.83
70 Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation. J Heart Lung Transplant 2011 0.83
71 Prognostic value of multiple biomarkers in American Indians free of clinically overt cardiovascular disease (from the Strong Heart Study). Am J Cardiol 2009 0.82
72 Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. Transplantation 2013 0.82
73 Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken) 2011 0.81
74 Impaired functional status and echocardiographic abnormalities signifying global dysfunction enhance the prognostic significance of previously unrecognized myocardial infarction detected by electrocardiography. Ann Noninvasive Electrocardiol 2007 0.80
75 Is self-reported "moderate" drinking in the cardiovascular benefit range associated with alcoholic behavior? A population based study. J Addict Dis 2009 0.80
76 Impact of chronic changes in arterial compliance and resistance on left ventricular ageing in humans. Eur J Heart Fail 2014 0.79
77 Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacity. Mayo Clin Proc 2002 0.78
78 Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation 2007 0.78
79 Identification of optimal electrocardiographic criteria for the diagnosis of unrecognized myocardial infarction: a population-based study. Ann Noninvasive Electrocardiol 2005 0.78
80 Long-term outcome and the use of revascularization in patients with heart failure, suspected ischemic heart disease, and large reversible myocardial perfusion defects. Am Heart J 2002 0.77
81 Relationship of myocardial perfusion imaging findings to outcome of patients with heart failure and suspected ischemic heart disease. Am Heart J 2004 0.76
82 Hypertension and heart failure: the ALLHAT imperative. Circulation 2011 0.76
83 Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation 2013 0.76
84 Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular function. Eur J Heart Fail 2002 0.75
85 Implementing clinical trial results into clinical practice for patients with heart failure. Am J Cardiol 2003 0.75
86 The case for selective re-issuance of medical certificates to allow pilots who have received a heart transplant to resume flying. J Heart Lung Transplant 2005 0.75